$44.25
0.110.25%
Pre-Market: 7:01 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for CVS Health (CVS) was reported on October 18, 2024 for Q3 2024. The company provided earnings per share guidance in the range of $1.05 to $1.10, compared to the estimated EPS of $1.70. Additionally, CVS Health forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.